CVE-2026-54765

Home/CVE/Traefik is an open source HTTP reverse proxy and load balancer. From v3.7.0 prior to v3.7.6, Traefik's Kubernetes Gatewa

CVE

↯ PDF report

Traefik is an open source HTTP reverse proxy and load balancer. From v3.7.0 prior to v3.7.6, Traefik's Kubernetes Gatewa

Traefik is an open source HTTP reverse proxy and load balancer. From v3.7.0 prior to v3.7.6, Traefik's Kubernetes Gateway API provider may resolve two accepted HTTPRoutes that target the same backend Service:port but configure different backendRef filters to the same child service and apply only one route's filter set to all requests reaching that backend. In Gateway deployments where backendRef filters set security-sensitive headers, such as tenant identity, authorization context, or values the backend trusts, an attacker who can create an accepted HTTPRoute sharing the same backend Service:port may cause their route's filter context to be applied to another route's requests, potentially crossing namespace boundaries when a ReferenceGrant permits cross-namespace targeting.

This issue is fixed in version v3.7.6.

EPSS 0.00427

EPSS exploitation odds0.43% · top 65%

Monitor

⚠ NVD has not scored this CVE yet - manual triage required (common for recent CVEs)

No Sigma yet — build one → YARA rules0

Look this up elsewhere - one-click external pivots

NVD CVE.org CISA Exploit-DB GitHub PoC VulnCheck KEV GreyNoise

▸ How to read a CVE - triage first, then detect and patch

This page is every public fact about CVE-2026-54765, cross-linked. Its job is to answer one question fast - does this need my attention now? - and then hand you the two things you do about it. Here is how an analyst reads it.

Triage: should I act now? Four signals, and they are not interchangeable:

CVSSseverity - how bad it is IF exploited, 0-10. A high CVSS alone is not urgency; a flaw can be a perfect 10 and never actually be attacked. EPSSprobability - a model’s estimate of the chance it is exploited in the next 30 days, 0-1. This is the “will it actually happen” signal. CISA KEVconfirmed - it is being exploited in the wild right now. The strongest signal on the page; KEV beats any score. Weaponisedavailability - public exploits / PoCs, and especially Metasploit modules rated Excellent / Great. Reliable, packaged exploit code means low-skill attackers can use it today.

How they combine: KEV, or a dependable Metasploit module, means patch now regardless of CVSS. High CVSS + low EPSS + no exploit is real but not an emergency - schedule it. Low CVSS but KEV-listed still gets patched now. The verdict above already weighed these for you; this is how it got there.

Then what - two workflows:

Detectwhen you cannot patch today, follow this CVE to the ATT&CK techniques it enables, then Build a SIEM detection (the green button) - author a rule, test it in Atomic, deploy it. That buys visibility while the patch waits. PatchAffected products / packages tell you if you are exposed; Fixed versions by distribution and Vendor advisories give the exact version that closes it.

Reading order for the panels below: verdict + badges, then Public exploits / Metasploit (is it weaponised), then ATT&CK techniques + Sigma / IDS rules (can I detect it), then Affected products / packages + Fixed versions (am I exposed, what patches it), then Threat actors / IOCs (who uses it), then Scoring & timeline / references (the evidence).

▣

Severity & exploitation scoring

EPSS exploitation probability

0.43%

Top 65%odds of exploitation in the next 30 days

CVSS metric silhouette

No structured CVSS vector for this CVE. Older entries often have only a numeric base score - the metric breakdown radar requires a full AV:_/AC:_/... vector string published by NVD.

SSVC triage

No SSVC vulnrichment for this CVE. CISA's Vulnrichment program scores newer CVEs (~2024 onwards) plus selected older critical ones. Use the EPSS probability + KEV status to triage instead.

Attack path

Full kill chain

→

◆

ATT&CK techniques

Techniques this CVE enables. Pills with a solid outline are high confidence - named directly in ATT&CK or Nuclei, or human-curated by CTID; the rest are inferred from the weakness type using MITRE's CVE Mapping Methodology and the CWE → CAPEC chain. Broad, generic-weakness guesses are filtered out. A small N× marks a technique that N independent sources agree on.